ReviewMolecular cancer2022

Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy.

Mohammed Fatih Rasul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.